Radiation Oncology·New Hyde Park, NY

Zucker School of Medicine at Hofstra/Northwell

Signal lift54%72%+18 pp with a signal here
Allocate signal →Track an away here25-26 cycle · applicant-level
Step 2 invited
223–261
p10 – p90
Sample N
114
applicants this cycle
This cycle
-
no tracked aways yet
Match rate
1.8%
2 of 114 applicants
01Cohort funnelthis cycle
N = 114
Applied
114
100.0%
Invited
57
50%
Class size
2
1.8%
Any graduation yearAdvanced
Your fitZucker School of Medicine at Hofstra/Northwell Program

Create a free profile to see your personalized fit

Get started
Applicant profile2025 data

What successful applicants at this program look like.

See how competitive you are here

Compare your stats against applicants at Zucker School of Medicine at Hofstra

Create free account

Who to contact

Training sites3 hospitals
  • 1
    Long Island Jewish Medical Center-Northwell Health
    New Hyde Park, NY
    Primary
  • 2
    Zucker School of Medicine at Hofstra/Northwell
    Great Neck, NY
    Sponsor
  • 3
    North Shore University Hospital-Northwell Health
    Manhasset, NY
    Participant
Interview invites
Loading...
Score rangesinvited cohort
USMLE Step 2 CK223 – 261
180205230255280

Level 2 CE data not available

Interview rates
US MD
58%
US DO
50%
US IMG
36%
Non-US IMG
44%
Applicant origin
In-state
62%
Out-of-state
49%
Interview prepRadiation Oncology
personalTell me about yourself.★ common
specialtyWhy did you choose this specialty?★ common
programWhy are you interested in our program?★ common
behavioralWhat are your strengths and weaknesses?★ common
personalWhere do you see yourself in 5-10 years?★ common
Community resourcesRadiation Oncology · 25-26
Save this program

Add Zucker School of Medicine at Hofstra/Northwell to your list

Build a personal match list. Compare programs side-by-side, see how your timing stacks against peers, and get notified when peers hear back.

Next

Calculate your match probability for Radiation Oncology.

See how your profile compares across all programs.

Open calculator →

Program data, 2025 release. Not medical advice. © 2026 Rezumab LLC.